MLN8054

MLN8054 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MLN8054, covering 2008-04-01 to 2013-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies [Phase 1]